Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm
- PMID: 16401794
- DOI: 10.1001/archopht.124.1.116
Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm
Abstract
Objective: To examine vision-targeted health-related quality of life and psychosocial characteristics in patients with benign essential blepharospasm (BEB) compared with patients with hemifacial spasm (HFS).
Methods: Persons with BEB (n = 159) or HFS (n = 91) were identified based on International Classification of Diseases, Ninth Revision, Clinical Modifications codes with subsequent verification by record abstraction. Information regarding demographics, health characteristics, disease characteristics, and vision-targeted health-related quality of life was obtained through a telephone interview.
Results: For patients with BEB and HFS, the composite scores and subscale scores on the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) were low. Compared with patients with HFS, patients with BEB reported more depressive symptoms (P = .03), met the criteria for generalized anxiety disorder (P = .007), had lower NEI-VFQ-25 composite scores (P<.001), and had lower NEI-VFQ-25 subscale scores regarding general vision (P = .03), ocular pain (P<.001), distance activities (P = .001), driving (P<.001), and all of the vision-specific subscales addressing psychosocial issues.
Conclusions: Compared with patients with HFS, those with BEB experience a greater reduction in vision-targeted health-related quality of life and are more prone to symptoms of depression and anxiety. This underscores the inadequacy of current treatment options for BEB in light of the fact that these patients had been undergoing standard-of-care treatments for some time.
Comment in
-
Evaluating health-related quality of life in ophthalmic disease: practical considerations.Arch Ophthalmol. 2006 Jan;124(1):121-2. doi: 10.1001/archopht.124.1.121. Arch Ophthalmol. 2006. PMID: 16401795 No abstract available.
-
Health-related quality of life in blepharospasm and hemifacial spasm.Arch Ophthalmol. 2007 Aug;125(8):1141; author reply 1141. doi: 10.1001/archopht.125.8.1141-a. Arch Ophthalmol. 2007. PMID: 17698774 No abstract available.
Similar articles
-
Closely spaced stressful life events precede the onset of benign essential blepharospasm and hemifacial spasm.J Neuroophthalmol. 2007 Dec;27(4):275-80. doi: 10.1097/WNO.0b013e31815c4233. J Neuroophthalmol. 2007. PMID: 18090560
-
Vision- and health-related quality of life in patients with Behçet uveitis.Arch Ophthalmol. 2010 Oct;128(10):1265-71. doi: 10.1001/archophthalmol.2010.209. Arch Ophthalmol. 2010. PMID: 20937995
-
Evaluating health-related quality of life in ophthalmic disease: practical considerations.Arch Ophthalmol. 2006 Jan;124(1):121-2. doi: 10.1001/archopht.124.1.121. Arch Ophthalmol. 2006. PMID: 16401795 No abstract available.
-
Facial dystonias and rosacea: is there an association?Orbit. 2014 Aug;33(4):276-9. doi: 10.3109/01676830.2014.904379. Epub 2014 May 15. Orbit. 2014. PMID: 24831933 Review.
-
Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology.Ophthalmology. 2018 Sep;125(9):1459-1467. doi: 10.1016/j.ophtha.2018.03.013. Epub 2018 Apr 10. Ophthalmology. 2018. PMID: 29653859 Review.
Cited by
-
Treatment of Depression with Botulinum Toxin.Toxins (Basel). 2022 May 31;14(6):383. doi: 10.3390/toxins14060383. Toxins (Basel). 2022. PMID: 35737044 Free PMC article. Review.
-
Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study.Front Psychol. 2016 Oct 5;7:1492. doi: 10.3389/fpsyg.2016.01492. eCollection 2016. Front Psychol. 2016. PMID: 27761118 Free PMC article.
-
Assessment of vision-related quality of life in patients with homonymous visual field defects.Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1749-58. doi: 10.1007/s00417-007-0644-z. Epub 2007 Jul 25. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17653566
-
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm.J Neural Transm (Vienna). 2011 Feb;118(2):233-9. doi: 10.1007/s00702-010-0529-x. Epub 2010 Dec 16. J Neural Transm (Vienna). 2011. PMID: 21161715 Clinical Trial.
-
Blink index as a response predictor of blepharospasm to botulinum neurotoxin-A treatment.Brain Behav. 2021 Nov;11(11):e2374. doi: 10.1002/brb3.2374. Epub 2021 Sep 23. Brain Behav. 2021. PMID: 34555267 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous